No Data
Modalis Therapeutics Announces Change in Audit Firm
Modalis Therapeutics Expands Share Authorization for Enhanced Capital Strategy
Modalis Therapeutics Restructures Capital to Address Earnings Deficit
Modalis Therapeutics: Extraordinary Report
Base food, CaSy and others.
The large exercise of the first subscription rights with exercise price adjustment clause by Tusk HD will result in the issuance of 1.2 million shares starting from the 13th. The public tender offer by MBF Acceleration, which engages in acquiring securities such as BASE FOOD, has set the public offer price at 688 yen per share and is expected to maintain its listing even after the public offer. Enechange has recorded a subsidy income of 1.171 billion yen as non-operating revenue. The large exercise of the 15th subscription rights with exercise price adjustment clause by Modalis has been carried out on the 6th.
Modalis Therapeutics Reports Reduced Losses Due to Lower R&D Expenses